
Actavis will be able to sell defined quantities of a generic version or an authorized generic version of reformulated OxyContin as early as next year, according to Purdue Pharma L.P., the manufacturer of the opioid analgesic.

Actavis will be able to sell defined quantities of a generic version or an authorized generic version of reformulated OxyContin as early as next year, according to Purdue Pharma L.P., the manufacturer of the opioid analgesic.

Patients who fail to fill a new prescription for statin therapy have a number of reasons, including negative perceptions about the medication, a preference for lifestyle modifications, concerns about side effects, drug interactions, polypharmacy, and a perception that they do not need the drug, according to a study published by The American Journal of Managed Care.

The United States continues to have the highest prices for both medical procedures and prescription drugs, according to the “2012 Comparative Price Report,” released by the International Federation of Health Plans.

FDA approved a new fixed-dose combination ophthalmic suspension of a carbonic anhydrase inhibitor (brinzolamide 1.0%) and an alpha 2 adrenergic receptor agonist (brimonidine tartrate 0.2%), which is indicated for the reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.

FDA has approved a supplemental new drug application (sNDA) for lubiprostone (Amitiza, Sucampo Pharmaceuticals and Takeda Pharmaceuticals) 24 ?g twice daily as the first oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, noncancer pain.

The Drug Enforcement Administration (DEA) is providing free disposal of unwanted medications during the sixth National Drug Take-Back Day on Thursday, April 27.

To reach their full potential in healthcare delivery, community pharmacists must continue to participate, innovate, and communicate through the National Association of Chain Drug Stores (NACDS) for continued advancement, according to Gregory D. Wasson, chairman of the board of NACDS.

Former U.S. President Bill Clinton will deliver the keynote address at the National Community Pharmacists Association (NCPA) in October, NCPA announced April 19.

L-carnitine significantly improves cardiac health in patients after a heart attack, according to a multicenter team of investigators in a study published in Mayo Clinic Proceedings.

For critically ill adults with multiorgan failure, early supplementation with glutamine or antioxidants does not improve clinical outcomes, and glutamine may increase the mortality rate of this patient population, according to a study published in the April 18 issue of the New England Journal of Medicine.

Generic OxyContin is off the table, and the branded drug gets a label warning that abuse of the product will be difficult

Tamoxifen, raloxifene, or exemestane use by high-risk women will reduce cancer incidence by almost two-thirds

The companies' voluntary national recalls are based in sterility assurance concerns

Repercussions of PBM consolidation

The new organization begins by defining its terms

Regardless of its status as an herbal dietary supplement, St. John's Wort is a drug

Alogliptin approved as monotherapy and in two combinations

Remember that Norman Rockwell image of the friendly local pharmacist, running his shop his way? Now blink. Hey! It's still there

Memories of the phenobarb generation

A concise summary of what they didn't teach you in pharmacy school

Policies and procedures for implementation of changes to pharm tech certification will be released later this year

It took the sustained efforts of a few dedicated individuals to persuade the U.S. Postal Service to create a postage stamp honoring pharmacists. To commemorate some of those men and their work, reader John W. Owen, Sr., RPh, speaks up

While not too many bench pharmacists get a lunch hour, creative solutions are still possible. In theory, anyway

Effective communication is the keystone of pharmacy ethics in daily practice

Data from the RE-MEDY trial suggest that Pradaxa is as effective as warfarin for long-term, extended antithrombotic therapy in patients who have already received at least three months of anticoagulation for VTE

Patients will consult with pharmacists, RNs, and PAs during health consultations offered right in their own neighborhoods

The popular guide by Harold Silverman, PhD, is now available as an app for iPhones, iPods, and iPads

Built-in timer notes when bottle was last opened

Shenandoah University, RxAlly, RealCME, and Kerr Drug to collaborate under Pfizer grant

Associations issues results of Medication Management in Care Transitions project